Miris AB

Miris AB

Dela

Miris is a global Med Tech company who develops and sells solutions for human milk analysis. The purpose is to enable clinicians to practice individualized.

The products are used at neonatal intensive care units, milk banks and research centers worldwide.

16/09/2025

Empower Neonatal Nutrition with Miris HMA®
Visit mirissolutions.com to learn more

08/09/2025

Miris HMA® supports healthcare providers to confidently deliver the right nutrition to support healthy growth in preterm babies.

05/09/2025

Experience the Future of Neonatal Care with Miris at NANN!

27/08/2025

Read the article: “Individualized Target Fortification of Breast Milk with Protein, Carbohydrates, and Fat for Preterm Infants: Effect on Neurodevelopment”

The study highlights how tailored breast milk fortification can positively impact brain development in preterm infants. Discover how personalized nutrition strategies are making a difference in neonatal care. By adjusting protein, carbohydrates, and fat levels, researchers are seeing promising improvements in the cognitive and motor skills of these infants. This approach underscores the importance of meeting specific nutritional needs for optimal growth and development.

TV3 Uudised: Emapiimapank - elutähtis kingitus sadade laste jaoks 04/07/2025

TV3 Uudised: Emapiimapank - elutähtis kingitus sadade laste jaoks 29.06.2025Igal aastal sünnib üle viie protsendi Eesti lastest enneagsena. Kuna enneaegsete laste emadel ei teki sageli koheselt rinnapiima, on paljude jaoks ...

20/11/2024

Q3 rapport 2024:
chrome-extensio://efaidnbmnnnibpcajpcglclefindmkaj/https://mirissolutions.com/media.ashx/mirisq32024final.pdf

19/11/2024
28/08/2024

Miris Holding AB Halvårsrapport 2024:https://mb.cision.com/Main/11548/4029471/2965996.pdf

16/05/2024

Miris offentliggör slutligt utfall i företrädesemission https://mb.cision.com/Main/11548/3982550/2801005.pdf

News-article | Spotlight 10/05/2024

Miris meddelar att nyckelpersoner ur bolagets ledning ansöker om att teckna units utan företräde i pågående företrädesemission:

News-article | Spotlight Miris Holding AB (publ) ("Miris" eller "Bolaget") meddelar härmed att nyckelpersoner ur Bolagets ledning ansöker om att teckna units för cirka 1,2 MSEK utan företräde i pågående företrädesemission. Tecknarna är Bolagets VD Camilla Myhre Sandberg och Sales and Marketing Director Marie Ekhol...

Vill du placera din praktik längst upp i Klinik-listan i Uppsala?
Klicka här för att få din sponsrade notering.

Adress


Danmarksgatan 26
Uppsala
75323

Öppettider

Måndag 08:00 - 17:00
Tisdag 08:00 - 17:00
Onsdag 08:00 - 17:00
Torsdag 08:00 - 17:00
Fredag 08:00 - 17:00